Shopping Cart
- Remove All
 
Your shopping cart is currently empty
HBV-IN-45 is a selective and orally bioavailable HBV capsid assembly modulator, with an IC50 of 0.51 μM for HBcAg in HBC cells. [HBV-IN-45] demonstrates potent anti-HBV activity.

| Description | HBV-IN-45 is a selective and orally bioavailable HBV capsid assembly modulator, with an IC50 of 0.51 μM for HBcAg in HBC cells. [HBV-IN-45] demonstrates potent anti-HBV activity.  | 
| In vitro | HBV-IN-45 (compound 26f) inhibits the growth of HepG2 cells, with a CC₅₀ of 84.29 μM. Additionally, it suppresses HBV DNA in the supernatant of HepAD38 cells, demonstrating an EC₅₀ of 2.24 μM.  | 
| In vivo | HBV-IN-45 (compound 26f; 100 mg/kg; oral administration; twice daily for 14 days) effectively reduces HBV DNA levels in plasma without altering the levels of HBeAg in mouse serum or the liver enzyme GPT (ALT).  | 
| Formula | C16H16N2O2S | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.